Sarah Knerr
Assistant Professor, Health Systems and Population Health
Education
PhD University of Washington, 2015 (Health Services)MPH University of Washington, 2011 (Public Health Genetics)
BA Vassar College, 2007 (Biochemistry)
Contact Info
email: saknerr@uw.eduoffice: HRC 431
address:
University of Washington
3980 15th Ave NE
Seattle, WA 98195-1621
campus box: 351621
voice: 206-221-1755
Cancer prevention and control; translational genomics; stakeholder engagement; health and health care disparities
Sainkhuu S, Cunha-Cruz J, Rogers M, Knerr S, Bekemeier B. Evaluation of Training Gaps Among Public Health Practitioners in Washington State. J Public Health Manag Pract. 2020 Aug 6. doi: 10.1097/PHH.0000000000001184. [Epub ahead of print] PMID: 32810065
Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial. JNCI Cancer Spectr. 2021 Jan 14;5(1):pkaa114. doi: 10.1093/jncics/pkaa114. eCollection 2021 Feb. PMID: 33554037 PMCID: PMC7853161
Bowen DJ, Wang C, Cole AM, Norquist BM, Knerr S, Devine B, Shirts B, Cain K, Harris HM, Haile HG, Swisher EM. Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care. Contemp Clin Trials. 2020 Dec 26;101:106257. doi: 10.1016/j.cct.2020.106257. [Epub ahead of print] PMID: 33373667 PMCID: PMC8075171
Wernli KJ, Bowles EA, Knerr S, Leppig KA, Ehrlich K, Gao H, Schwartz MD, O'Neill SC. Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial. Perm J. 2020 Dec;24:1-4. doi: 10.7812/TPP/19.205. PMID: 33482952
Knerr S, West KM, Angelo FA. Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control. J Genet Couns. 2020 Jan 22. doi: 10.1002/jgc4.1216. [Epub ahead of print] PMID: 31967362
PubMed
DOI
Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial. JNCI Cancer Spectr. 2021 Jan 14;5(1):pkaa114. doi: 10.1093/jncics/pkaa114. eCollection 2021 Feb. PMID: 33554037 PMCID: PMC7853161
PubMed
PubMed Central
DOI
Bowen DJ, Wang C, Cole AM, Norquist BM, Knerr S, Devine B, Shirts B, Cain K, Harris HM, Haile HG, Swisher EM. Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care. Contemp Clin Trials. 2020 Dec 26;101:106257. doi: 10.1016/j.cct.2020.106257. [Epub ahead of print] PMID: 33373667 PMCID: PMC8075171
PubMed
PubMed Central
DOI
Wernli KJ, Bowles EA, Knerr S, Leppig KA, Ehrlich K, Gao H, Schwartz MD, O'Neill SC. Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial. Perm J. 2020 Dec;24:1-4. doi: 10.7812/TPP/19.205. PMID: 33482952
PubMed
DOI
Knerr S, West KM, Angelo FA. Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control. J Genet Couns. 2020 Jan 22. doi: 10.1002/jgc4.1216. [Epub ahead of print] PMID: 31967362
PubMed
DOI
2019
Member, thesis committee for Solongo Sainkhuu
Evaluating Training Gaps Among Public Health Practitioners in Washington State
Health Promotion and Disease Prevention Centers
Centers for Disease Control and Prevention (CDC)PI: Hannon Dates: 9/30/2021 - 9/29/2022
Optimizing Implementation in Cancer Control (OPTICC)
National Cancer Institute (NCI)PI: Weiner Dates: 9/1/2021 - 8/31/2022
eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants
National Institutes of Health (NIH)PI: Jarvik Dates: 5/1/2021 - 4/30/2022
Health Promotion and Disease Prevention Research Centers
Centers for Disease Control and Prevention (CDC)PI: Hannon Dates: 9/30/2020 - 9/29/2021
Exome sequencing in Diverse Populations in Colorado & Oregon
Kaiser Permanente Center for Health ResearchPI: Jarvik Dates: 6/1/2020 - 5/31/2021
eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants
National Institutes of Health (NIH)PI: Jarvik Dates: 4/1/2020 - 3/31/2025
Implementing the moon: Getting genomic testing to the public
National Institutes of Health (NIH)PI: Bowen Dates: 9/1/2019 - 8/31/2024
Population Management for Hereditary Cancer Prevention: Implementation, Effectiveness, and Acceptability Within A Learning Health System
National Institutes of Health (NIH)PI: Knerr Dates: 4/1/2019 - 3/31/2022